Skip to content

Monitoring of the Safety and the Performance of the Endoscopic Cap Electrode (ECE50)

Monitoring of the Safety and the Performance of the Endoscopic Cap Electrode (ECE50)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05245942
Acronym
ECE50
Enrollment
384
Registered
2022-02-18
Start date
2021-12-16
Completion date
2031-12-16
Last updated
2026-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laryngeal Dystonia, Vocal Fold Paresis

Brief summary

The objective of this registry is to confirm the safety and the performance of the ECE50 in medical routine by collecting data.

Detailed description

The Endoscopic Cap Electrode (ECE50) has been designed for the delivery of electrostimulation to selected laryngeal muscles. The primary objective of this registry is to retrieve real-life data on the safety and performance of the Endoscopic Cap in medical routine. Subject's participation will last a maximum of 2 hours. Upon successful conclusion of the screening session starts the testing session of the ECE50. The ECE50 has been designed to be placed on the top of a videoendoscope for the delivery of electrostimulation to the laryngeal region. The stimulation and reaction of the muscles can provide information about the presence and type of dysfunctions and thus influence the treatment procedure. Being a registry a collection of records generated within routine medical procedures with a medical device approved for the EU market, it does not pose additional risks for the patients participating in it.

Interventions

None listed

Sponsors

MED-EL Elektromedizinische Geräte GesmbH
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Legal adults (i.e., as a general rule patients ≥ 18 years old) * Legal adults requiring a diagnosis for a disorder that could be traced back to uni- or bilateral dysfunction of one or more laryngeal muscle(s) of the posterior cricoid region * Signed and dated informed consent before the start of any registry-specific procedure for all the recruited subjects

Exclusion criteria

* Lack of compliance with any inclusion criteria * Use of an active medical implant * Known allergies or intolerance to the material used for this registry * Parallel participation in a device/drug registry in the period of data collection, which could confound the results of the registry * Anything that, in the opinion of the Registry Responsible, would place the subject at increased risk or preclude the subject's full compliance with the general requirements of this registry

Design outcomes

Primary

MeasureTime frameDescription
Confirm the safetyImmediately after the interventionAdverse event report analysis
Assess the performance of the ECE50During the interventionComparison between the result of the ECE50 stimulation, Laryngeal Electromyography (LEMG), videolaryngoscopy

Secondary

MeasureTime frameDescription
Standardize the medical procedure for the ECE50Immediately after the interventionDescriptive evaluation of the ECE50 stimulation protocol

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026